RHON-KLINIKUM AG has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, a slight increase from EUR 833.5 million in the prior year. EBITDA rose to EUR 57.0 million from EUR 46.7 million, and consolidated profit grew to EUR 22.5 million from EUR 14.7 million. The company treated 513,700 patients on an outpatient and inpatient basis, a 9% increase year-over-year. These results reflect the company's ongoing efforts to expand regional healthcare networks and invest in medical technology.
The company is actively pursuing strategic partnerships to enhance regional care. In Hesse, Universitatsklinikum Marburg and Lungenfachklinik Immenhausen have formed a partnership to improve lung patient care. Meanwhile, in Brandenburg, the newly opened child protection emergency service at RHON-KLINIKUM Frankfurt (Oder) is part of a regional network with the City of Frankfurt (Oder) and the District of Oder-Spree, aiming to coordinate rapid assistance for children and adolescents.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: "Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs." He stressed that collaboration across providers is essential to ensure high-quality care, especially in rural areas.
However, the company faces significant challenges from recent legislation. Dr. Stefan Stranz, also on the Board of Management, noted: "The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks." The Hospital Reform Adjustment Act (KHAG) and the SHI Contribution Rate Stabilisation Act (GKV-BStabG) are intended to improve quality and efficiency but are expected to increase financial pressure on hospitals in the short term.
Looking ahead, RHON-KLINIKUM AG expects revenues of EUR 1.7 billion (plus or minus 5%) and EBITDA between EUR 110 million and EUR 125 million for the full year 2026. The company also monitors non-financial indicators such as number of cases and cost weights, anticipating moderate improvement. However, the forecast is subject to considerable uncertainties due to ongoing regulatory changes, global crises, and economic volatility, which could impact prices, supply chains, and market stability.
The company's interim report is available on its website. RHON-KLINIKUM AG remains one of Germany's largest healthcare providers, operating five hospitals including Campus Bad Neustadt, Zentralklinik Bad Berka, Klinikum Frankfurt (Oder), and the Giessen and Marburg University Hospitals (UKGM). With over 19,100 employees, the group treats approximately 938,000 patients annually and is part of the ASKLEPIOS Group.
